To account for the expanded patient cohort and the expected differences in observed costs, the measure is stratified into three sub-groups based on diagnosis and each sub-group uses a separate risk adjustment model
Glutathione acts as a master antioxidant, detoxifying the body and protecting cells, while Vitamin C and Zinc further strengthen immune defenses and promote cellular health
This dosage range has been clinically shown to raise blood glutathione levels and support skin and liver health
dietary sources include green leafy vegetables
As described in the example in the CY 2025 PFS proposed rule (89 FR 61977), if CMS receives a likely to be in shortage rebate reduction request for a generic Part D rebatable drug that was submitted on August 15, 2024, and that generic Part D rebatable drug is currently in shortage from September 15, 2025, until May 15, 2028, CMS will apply a 75 percent reduction in the total rebate amount for the duration of the applicable period for which the likely to be in shortage rebate reduction request was granted (that is, October 1, 2024, to September 30, 2025), and then would apply the shortage reduction as set forth in 428.301, beginning with a reduction of 75 percent for a generic Part D rebatable drug for the applicable period beginning October 1, 2025, followed by a reduction of 50 percent for the applicable period beginning October 1, 2026, and a 25 percent reduction for the applicable period beginning October 1, 2027
